Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer.
Mirte MullerMyron G BestVincent van der NoortT Jeroen N HiltermannAnna-Larissa N NiemeijerEdward PostNik SolSjors G J G In 't VeldTineke NogaredeLisanne VisserRobert D SchoutenDaan van den BroekKarlijn HummelinkKim MonkhorstAdrianus J de LangenEd SchuuringEgbert F SmitHarry J M GroenThomas WurdingerMichel M van den HeuvelPublished in: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine (2023)
We concluded that platelet RNA may have minimally discriminative capacity for anti-PD1 nivolumab response prediction, with which the current methodology is insufficient for diagnostic application.
Keyphrases